Cargando…
Immunotherapeutic Strategies for Neuroblastoma: Present, Past and Future
Neuroblastoma is the most common extracranial pediatric solid tumor with a heterogeneous clinical course, ranging from spontaneous regression to metastatic disease and death, irrespective of intensive chemotherapeutic regimen. On the basis of several parameters, children affected by neuroblastoma ar...
Autores principales: | Morandi, Fabio, Sabatini, Federica, Podestà, Marina, Airoldi, Irma |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7828327/ https://www.ncbi.nlm.nih.gov/pubmed/33450862 http://dx.doi.org/10.3390/vaccines9010043 |
Ejemplares similares
-
Novel Immunotherapeutic Approaches for Neuroblastoma and Malignant Melanoma
por: Morandi, Fabio, et al.
Publicado: (2018) -
The Role of Extracellular Vesicles in the Progression of Human Neuroblastoma
por: Marimpietri, Danilo, et al.
Publicado: (2021) -
HLA-G and Other Immune Checkpoint Molecules as Targets for Novel Combined Immunotherapies
por: Morandi, Fabio, et al.
Publicado: (2022) -
Genomic profile of MYCN non-amplified neuroblastoma and potential for immunotherapeutic strategies in neuroblastoma
por: Lee, Eunjin, et al.
Publicado: (2020) -
Immune Checkpoints in Pediatric Solid Tumors: Targetable Pathways for Advanced Therapeutic Purposes
por: Cocco, Claudia, et al.
Publicado: (2021)